Drug Profile
Acarbose/metformin - Lotus Pharmaceuticals
Alternative Names: Acarmet F.C. tabletsLatest Information Update: 01 Jul 2019
Price :
$50
*
At a glance
- Originator Lotus Pharmaceuticals
- Class Antihyperglycaemics; Biguanides; Small molecules
- Mechanism of Action Alpha-glucosidase inhibitors; AMP activated protein kinase stimulants; Gluconeogenesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Type 2 diabetes mellitus
Most Recent Events
- 01 Jul 2019 Chemical structure information added
- 29 Jan 2019 Acarbose/metformin is not yet available for Type 2 diabetes mellitus in Taiwan
- 01 Nov 2010 Phase-III clinical trials in Type-2 diabetes mellitus in Taiwan (PO)